{"url_path":"/sec/anab/8-k/2026-08-11/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1370053/0001193125-26-344583-index.html","accession_number":"0001193125-26-344583","cik":"0001370053","ticker":"ANAB","issuer_name":"ANAPTYSBIO, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1370053/0001193125-26-344583-index.html","primary_entity_key":"0001370053","primary_entity_name":"ANAPTYSBIO, INC"},"word_count":188,"has_tables":true,"body_markdown":"## Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn August 11, 2026, AnaptysBio, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders and the following proposals were adopted:\n\n \n\n1.\nElection of two Class III directors, Hollings Renton and John P. Schmid, each to serve a three-year term, which will expire at the 2029 Annual Meeting of Stockholders or until such time as his respective successor has been duly elected and qualified or until such director’s earlier resignation or removal:\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nNominees\n\n \n\nShares For\n\n \n\nShares Withheld / Abstaining\n\n \n\nBroker Non-Votes\n\nHollings Renton\n\n \n\n15,304,522\n\n \n\n6,613,642\n\n \n\n2,084,465\n\nJohn P. Schmid\n\n \n\n20,314,669\n\n \n\n1,603,495\n\n \n\n2,084,465\n\n \n\n2.\nRatification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2027:\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nShares For\n\n \n\nShares Against\n\n \n\nShares Withheld/Abstaining\n\n \n\nBroker Non-Votes\n\n22,343,352\n\n \n\n1,640,401\n\n \n\n18,876\n\n \n\n-\n\n \n\n3.\nNon-binding, advisory approval of compensation paid to the Company’s named executive officers:\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nShares For\n\n \n\nShares Against\n\n \n\nShares Withheld/Abstaining\n\n \n\nBroker Non-Votes\n\n21,274,791\n\n \n\n609,979\n\n \n\n33,394\n\n \n\n2,084,465\n\n \n\n4.\nApproval of the amendment to the Company’s 2017 Equity Incentive Plan:\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nShares For\n\n \n\nShares Against\n\n \n\nShares Withheld/Abstaining\n\n \n\nBroker Non-Votes\n\n15,563,882\n\n \n\n6,332,813\n\n \n\n21,469\n\n \n\n2,084,465"}